These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 23531115)

  • 1. Serotonergic drugs for depression and beyond.
    Stahl SM; Lee-Zimmerman C; Cartwright S; Morrissette DA
    Curr Drug Targets; 2013 May; 14(5):578-85. PubMed ID: 23531115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Other Antidepressants.
    Schwasinger-Schmidt TE; Macaluso M
    Handb Exp Pharmacol; 2019; 250():325-355. PubMed ID: 30194544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depression and serotonin: a never ending story.
    Marazziti D
    Curr Drug Targets; 2013 May; 14(5):513. PubMed ID: 23547753
    [No Abstract]   [Full Text] [Related]  

  • 4. Association of changes in norepinephrine and serotonin transporter expression with the long-term behavioral effects of antidepressant drugs.
    Zhao Z; Zhang HT; Bootzin E; Millan MJ; O'Donnell JM
    Neuropsychopharmacology; 2009 May; 34(6):1467-81. PubMed ID: 18923402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New-Generation, Non-SSRI Antidepressants: Therapeutic Drug Monitoring and Pharmacological Interactions. Part 1: SNRIs, SMSs, SARIs.
    Mandrioli R; Protti M; Mercolini L
    Curr Med Chem; 2018; 25(7):772-792. PubMed ID: 28707591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined α7 nicotinic acetylcholine receptor agonism and partial serotonin transporter inhibition produce antidepressant-like effects in the mouse forced swim and tail suspension tests: a comparison of SSR180711 and PNU-282987.
    Andreasen JT; Redrobe JP; Nielsen EØ
    Pharmacol Biochem Behav; 2012 Jan; 100(3):624-9. PubMed ID: 22108649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonin Transporter-Independent Actions of the Antidepressant Vortioxetine As Revealed Using the SERT Met172 Mouse.
    Nackenoff AG; Simmler LD; Baganz NL; Pehrson AL; Sánchez C; Blakely RD
    ACS Chem Neurosci; 2017 May; 8(5):1092-1100. PubMed ID: 28272863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modes and nodes explain the mechanism of action of vortioxetine, a multimodal agent (MMA): enhancing serotonin release by combining serotonin (5HT) transporter inhibition with actions at 5HT receptors (5HT1A, 5HT1B, 5HT1D, 5HT7 receptors).
    Stahl SM
    CNS Spectr; 2015 Apr; 20(2):93-7. PubMed ID: 25831967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Essential Contributions of Serotonin Transporter Inhibition to the Acute and Chronic Actions of Fluoxetine and Citalopram in the SERT Met172 Mouse.
    Nackenoff AG; Moussa-Tooks AB; McMeekin AM; Veenstra-VanderWeele J; Blakely RD
    Neuropsychopharmacology; 2016 Jun; 41(7):1733-41. PubMed ID: 26514584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drugs which influence serotonin transporter and serotonergic receptors: Pharmacological and clinical properties in the treatment of depression.
    Taciak PP; Lysenko N; Mazurek AP
    Pharmacol Rep; 2018 Feb; 70(1):37-46. PubMed ID: 29309998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel serotonergic mechanisms and clinical experience with nefazodone.
    Fontaine R
    Clin Neuropharmacol; 1993; 16 Suppl 3():S45-50. PubMed ID: 8131154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NK1 receptor antagonism lowers occupancy requirement for antidepressant-like effects of SSRIs in the gerbil forced swim test.
    Lelas S; Li YW; Wallace-Boone TL; Taber MT; Newton AE; Pieschl RL; Davis CD; Molski TF; Newberry KS; Parker MF; Gillman KW; Bronson JJ; Macor JE; Lodge NJ
    Neuropharmacology; 2013 Oct; 73():232-40. PubMed ID: 23770339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent developments in the design of anti-depressive therapies: targeting the serotonin transporter.
    Butler SG; Meegan MJ
    Curr Med Chem; 2008; 15(17):1737-61. PubMed ID: 18673223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimates of serotonin and norepinephrine transporter inhibition in depressed patients treated with paroxetine or venlafaxine.
    Owens MJ; Krulewicz S; Simon JS; Sheehan DV; Thase ME; Carpenter DJ; Plott SJ; Nemeroff CB
    Neuropsychopharmacology; 2008 Dec; 33(13):3201-12. PubMed ID: 18418363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biaryls as potent, tunable dual neurokinin 1 receptor antagonists and serotonin transporter inhibitors.
    Degnan AP; Tora GO; Han Y; Rajamani R; Bertekap R; Krause R; Davis CD; Hu J; Morgan D; Taylor SJ; Krause K; Li YW; Mattson G; Cunningham MA; Taber MT; Lodge NJ; Bronson JJ; Gillman KW; Macor JE
    Bioorg Med Chem Lett; 2015 Aug; 25(15):3039-43. PubMed ID: 26048800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SNRIs achieve faster antidepressant effects than SSRIs by elevating the concentrations of dopamine in the forebrain.
    Li J; Lu C; Gao Z; Feng Y; Luo H; Lu T; Sun X; Hu J; Luo Y
    Neuropharmacology; 2020 Oct; 177():108237. PubMed ID: 32710978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antidepressant drug vilazodone is an allosteric inhibitor of the serotonin transporter.
    Plenge P; Yang D; Salomon K; Laursen L; Kalenderoglou IE; Newman AH; Gouaux E; Coleman JA; Loland CJ
    Nat Commun; 2021 Aug; 12(1):5063. PubMed ID: 34417466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Basic psychopharmacology of antidepressants, part 1: Antidepressants have seven distinct mechanisms of action.
    Stahl SM
    J Clin Psychiatry; 1998; 59 Suppl 4():5-14. PubMed ID: 9554316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current and Future Perspectives on the Major Depressive Disorder: Focus on the New Multimodal Antidepressant Vortioxetine.
    Orsolini L; Tomasetti C; Valchera A; Iasevoli F; Buonaguro EF; Fornaro M; Fiengo ALC; Martinotti G; Vellante F; Matarazzo I; Vecchiotti R; Perna G; Di Nicola M; Carano A; Di Bartolomeis A; De Giannantonio M; De Berardis D
    CNS Neurol Disord Drug Targets; 2017; 16(1):65-92. PubMed ID: 27781949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacology of antidepressants: selectivity or multiplicity?
    Westenberg HG
    J Clin Psychiatry; 1999; 60 Suppl 17():4-8; discussion 46-8. PubMed ID: 10446734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.